Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: An in vitro and inzovo approach

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 11, 2010, Pages 7082-7087

  Lin, Chiu Mei ^a,b,c   Shyu, Kou Gi ^a   Wang, Bao Wei ^a   Chang, Hang ^a,c   Chen, Yen Hsu ^d,e   Chiu, Jen Hwey ^f,g  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL ILAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Chrysin; Gp130 JAK1 STAT3; IL 6; VEGF

Indexed keywords

CHRYSIN; FLAVONOID; INTERLEUKIN 6; JANUS KINASE 1; STAT3 PROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL CULTURE; CHICKEN; CHORIOALLANTOIS; DOWN REGULATION; DRUG EFFECT; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELLS, CULTURED; CHICKENS; CHORIOALLANTOIC MEMBRANE; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; INTERLEUKIN-6; JANUS KINASE 1; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

SPONDIAS PURPUREA;

EID: 77953155164     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf100421w     Document Type: Article

References (35)

1. Zheng, X.; Zhao, F. F.; Liu, Y. M.; Yao, X.; Zheng, Z. T.; Luo, X.; Liao, D. F. Synthesis and preliminary biological evaluation of chrysin derivatives as potential anticancer drugs. Med. Chem. 2010, 6, 6 - 8.
2. Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways Mol. Nutr. Food Res. 2008, 52, 507-526
3. Schindler, R.; Mentlein, R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells J. Nutr. 2006, 136, 1477-1482
4. Beck, L., Jr.; D'Amore, P. A. Vascular development: cellular and molecular regulation FASEB J. 1997, 11, 365-373
5. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1995, 1, 27-31
6. Ikonomidis, I.; Athanassopoulos, G.; Stamatelopoulos, K.; Lekakis, J.; Revela, I.; Venetsanou, K.; Marinou, M.; Monaco, C.; Cokkinos, D. V.; Nihoyannopoulos, P. Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study Am. Heart J. 2008, 156, 269-276
7. Bachelot, T.; Ray-Coquard, I.; Menetrier-Caux, C.; Rastkha, M.; Duc, A.; Blay, J. Y. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients Br. J. Cancer 2003, 88, 1721-1726
8. Banerjee, I.; Fuseler, J. W.; Intwala, A. R.; Baudino, T. A. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H1694-H1704
9. Loeffler, S.; Fayard, B.; Weis, J.; Weissenberger, J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1 Int. J. Cancer 2005, 115, 202-213
10. Heinrich, P. C.; Behrmann, I.; Haan, S.; Hermanns, H. M.; Muller-Newen, G.; Schaper, F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem. J. 2003, 374, 1-20
11. Chen, S. H.; Murphy, D. A.; Lassoued, W.; Thurston, G.; Feldman, M. D.; Lee, W. M. Activated STAT3 is a mediator and biomarker of VEGF endothelial activation Cancer Biol. Ther. 2008, 7, 1994-2003
12. Jaffe, E. A.; Nachman, R. L.; Becker, C. G.; Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J. Clin. Invest. 1973, 52, 2745-2756
13. Auerbach, R.; Lewis, R.; Shinners, B.; Kubai, L.; Akhtar, N. Angiogenesis assays: a critical overview Clin. Chem. 2003, 49, 32-40
14. Lin, C. M.; Chang, H.; Chen, Y. H.; Li, S. Y.; Wu, I. H.; Chiu, J. H. Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1 Int. Immunopharmacol. 2006, 6, 1690-1698
15. Matsubara, K.; Kaneyuki, T.; Miyake, T.; Mori, M. Antiangiogenic activity of nasunin, an antioxidant anthocyanin, in eggplant peels J. Agric. Food Chem. 2005, 53, 6272-6275
16. Wang, B. W.; Chang, H.; Lin, S.; Kuan, P.; Shyu, K. G. Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-α in cultured human umbilical vein endothelial cells Cardiovasc. Res. 2003, 59, 460-469
17. Izumi-Nagai, K.; Nagai, N.; Ozawa, Y.; Mihara, M.; Ohsugi, Y.; Kurihara, T.; Koto, T.; Satofuka, S.; Inoue, M.; Tsubota, K.; Okano, H.; Oike, Y.; Ishida, S. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization Am. J. Pathol. 2007, 170, 2149-2158
18. Yang, S. H.; Lin, J. K.; Huang, C. J.; Chen, W. S.; Li, S. Y.; Chiu, J. H. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation J. Surg. Res. 2005, 128, 140-146
19. Ahn, M. R.; Kunimasa, K.; Kumazawa, S.; Nakayama, T.; Kaji, K.; Uto, Y.; Hori, H.; Nagasawa, H.; Ohta, T. Correlation between antiangiogenic activity and antioxidant activity of various components from propolis Mol. Nutr. Food Res. 2009, 53, 643-651
20. Lin, C. M.; Chang, H.; Li, S. Y.; Wu, I. H.; Chiu, J. H. Chrysin inhibits lipopolysaccharide-induced angiogenesis via down-regulation of VEGF/VEGFR-2(KDR) and IL-6/IL-6R pathways Planta Med. 2006, 72, 708-714
21. Leung, K. W.; Barnstable, C. J.; Tombran-Tink, J. Bacterial endotxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling Mol. Immunol. 2009, 46, 1374-1386
22. Fu, B.; Xue, J.; Li, Z.; Shi, X.; Jiang, B. H.; Fang, J. Chrysin inhibits expression of hypoxia-inducible factor-1α through reducing hypoxia-inducible factor-1α stability and inhibiting its protein synthesis Mol. Cancer Ther. 2007, 6, 220-226
23. López-Posadas, R.; Ballester, I.; Abadía-Molina, A. C.; Suárez, M. D.; Zarzuelo, A.; Martínez-Augustin, O.; Sánchez de Medina, F. Effect of flavonoids on rat splenocytes, a structure-activity relationship study Biochem. Pharmacol. 2008, 76, 495-506
24. Peng, S. M.; Zou, X. Q.; Ding, H. L.; Ding, Y. L.; Lin, Y. B. Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors Bioorg. Med. Chem. Lett. 2009, 19, 1264-1266
25. Raina, K.; Rajamanickam, S.; Singh, R. P.; Deep, G.; Chittezhath, M.; Agarwal, R. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model Cancer Res. 2008, 68, 6822-6830
26. Raina, K.; Rajamanickam, S.; Singh, R. P.; Deep, G.; Chittezhath, M.; Agarwal, R. Comparison of flavonoids and isoflavonoids as antioxidants J. Agric. Food Chem. 2009, 57, 3780-3785
27. Lee, Y. W.; Lee, W. H. Protective effects of genistein on proinflammatory pathways in human brain microvascular endothelial cells J. Nutr. Biochem. 2008, 19, 819-825
28. Shin, E. K.; Kwon, H. S.; Kim, Y. H.; Shin, H. K.; Kim, J. K. Chrysin, a natural flavone, improves murine inflammatory bowel diseases Biochem. Biophys. Res. Commun. 2009, 381, 502-507
29. Woo, K. J.; Jeong, Y. J.; Inoue, H.; Park, J. W.; Kwon, T. K. Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity FEBS Lett. 2005, 579, 705-711
30. Regis, G.; Pensa, S.; Boselli, D.; Novelli, F.; Poli, V. Ups and downs: the STAT1:STAT3 seesaw of interferon and gp130 receptor signalling Semin. Cell Dev. Biol. 2008, 19, 351-359
31. Yahata, Y.; Shirakata, Y.; Tokumaru, S.; Yamasaki, K.; Sayama, K.; Hanakawa, Y.; Detmar, M.; Hashimoto, K. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation J. Biol. Chem. 2003, 278, 40026-40031
32. Choi, J. S.; Choi, Y. J.; Shin, S. Y.; Li, J.; Kang, S. W.; Bae, J. Y.; Kim, D. S.; Ji, G. E.; Kang, J. S.; Kang, Y. H. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-signaling J. Nutr. 2008, 138, 983-990
33. Masuda, M.; Ruan, H. Y.; Ito, A.; Nakashima, T.; Toh, S.; Wakasaki, T.; Yasumatsu, R.; Kutratomi, Y.; Komune, S.; Weinstein, I. B. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma Oral Oncol. 2007, 43, 785-790.
34. Tyagi, A.; Singh, R. P.; Ramasamy, K.; Raina, K.; Redente, E. F.; Dwyer-Nield, L. D.; Radcliffe, R. A.; Malkinson, A. M.; Agarwal, R. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-κB and signal transducers and activators of transcription 3 Cancer Prev. Res. (Phila. Pa.) 2009, 2, 74-83.
35. Singh-Gupta, V.; Zhang, H.; Banerjee, S.; Kong, D.; Raffoul, J. J.; Sarkar, F. H.; Hillman, G. G. Radiation-induced HIF-1α cell survival pathway is inhibited by soy isoflavones in prostate cancer cells Int. J. Cancer 2009, 124, 1675-1684.